Stock market averages began the month of March with a day for the record books, immediately after a week of record-setting price action to close out the month of February.
On Monday, the Dow Jones Industrial Average (^DJI) posted its single largest point gain ever of +1,293.76 or +5.1% to close at 26,703.32. This came only 2 days after the the DJIA posted its single largest point loss of -1,190.95 or -4.4% on Thursday, February 27.
The S&P 500 (^SPX) was +136.00 or +4.6% to close at 3,090.23 and also logged its largest 1-day point gain ever. It was the largest percentage gain since December 26, 2018. For the S&P 500, this comes one day after posting a weekly decline of -11.5%, only its fifth weekly decline of -10% or more since it was introduced as a market benchmark by Standard and Poors in 1957.
The Nasdaq Composite (^IXIC) closed up +384.80, or +4.49% at 8,952.16.
The beginning of what might become a “V” shaped technical reversal is very reminiscent of what occurred during the last two weeks of 2018.
From December 13, 2018 to December 24, the DJIA and S&P 500 had declines of -11.4% and -11.3% over seven trading days.
On December 26, the following day, the DJIA rallied +1,086 points or +4.98%, almost exactly matched by the S&P 500, which gained +116.60 points or +4.96%.
While the fundamental backdrop of today and late 2018 are very different, the very sharp rebound after a five- and seven-day decline has been eerily similar, at least for one day.
Stay tuned. No doubt there is much more volatility to come.
The most damning journalistic sin committed by the media during the era of Russia collusion…
The first ecological study finds mask mandates were not effective at slowing the spread of…
On "What Are the Odds?" Monday, Robert Barnes and Rich Baris note how big tech…
On "What Are the Odds?" Monday, Robert Barnes and Rich Baris discuss why America First…
Personal income fell $1,516.6 billion (7.1%) in February, roughly the consensus forecast, while consumer spending…
Research finds those previously infected by or vaccinated against SARS-CoV-2 are not at risk of…
This website uses cookies.